跳至主要内容
临床试验/NCT01879761
NCT01879761进行中(未招募)不适用

Immune Resolution After Staphylococcus Aureus Bacteremia

University of Chicago2 个研究点 分布在 1 个国家目标入组 102 人开始时间: 2013年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
102
试验地点
2
主要终点
HLA-DR and cytokines

研究概览

简要总结

The purpose of this study is to determine how monocyte HLA-DR and other markers of immune function change with time in patients with and without prior immune dysfunction who survive sepsis from Staphylococcus aureus bacteremia.

We hypothesize that patients with prior immune dysfunction will have greater reductions in HLA-DR and other markers of immune function after an episode of sepsis than people who do not have prior immune dysfunction.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least one blood culture positive for S. aureus
  • Patients aged ≥18 years
  • At least two of four systemic inflammatory response syndrome (SIRS) criteria on the day of positive blood cultures. SIRS criteria are:
  • Body temperature less than 36°C(96.8°F) or greater than 38°C(100.4°F)
  • Heart rate greater than 90 beats per minute
  • Tachypnea (high respiratory rate), with greater than 20 breaths per minute; or, an arterial partial pressure of carbon dioxide less than 32 mmHg
  • WBC less than 4000 cells/mm³ (4 x 109 cells/L) or greater than 12,000 cells/mm³ (12 x 109 cells/L); or the presence of greater than 10% immature neutrophils (band forms)

排除标准

  • Sequential Organ Failure Assessment (SOFA) score > 12 on day of positive blood cultures
  • Survival expected to be < 7 days from positive blood cultures

研究组 & 干预措施

Immunosuppressed

Immunosuppressed includes patients with any one of the following:

  1. a diagnosis of a hematological malignancy
  2. a diagnosis of HIV
  3. myelosuppressive chemotherapy in the previous 90 days
  4. immune-modulating medications in the previous 90 days

Non-Immunosuppressed

Subject does not fit immunosuppressed criteria

结局指标

主要结局

HLA-DR and cytokines

时间窗: 0-30 days

Percent expression of HLA-DR on monocytes will be measured by flow cytometry. Cytokine levels will be measured by ELISA.

次要结局

  • New Infections(0-90 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Immune Resolution After Staphylococcus Aureus... | 临床试验